EIT Health - Congratulations to Altoida for raising $6.3M Series A to Predict Alzheimer's Disease Risk Using Artificial Intelligence, Machine Learning and Augmented Reality. Altoida CSO – Dr. Ioannis Tarnanas was the
![Description of the Method for Evaluating Digital Endpoints in Alzheimer Disease Study: Protocol for an Exploratory, Cross-sectional Study | Global Brain Health Institute Description of the Method for Evaluating Digital Endpoints in Alzheimer Disease Study: Protocol for an Exploratory, Cross-sectional Study | Global Brain Health Institute](https://www.gbhi.org/sites/default/files/styles/square/public/images/2023-01/GettyImages-1313978931.jpg?h=af5760ac&itok=t-OQ91vX)
Description of the Method for Evaluating Digital Endpoints in Alzheimer Disease Study: Protocol for an Exploratory, Cross-sectional Study | Global Brain Health Institute
![DEPARTMENT OF INFORMATICS | Forbes article about the Ionian Universitys Laboratory of Bioinformatics and Human Electrophysiology research DEPARTMENT OF INFORMATICS | Forbes article about the Ionian Universitys Laboratory of Bioinformatics and Human Electrophysiology research](https://ionio.gr/images/content/news/11000-11999/IU-ni-11472-80274.jpg)
DEPARTMENT OF INFORMATICS | Forbes article about the Ionian Universitys Laboratory of Bioinformatics and Human Electrophysiology research
![The European Institute of Innovation and Technology (EIT) announces winners of the 2018 EIT Awards on 10th anniversary - Business Review The European Institute of Innovation and Technology (EIT) announces winners of the 2018 EIT Awards on 10th anniversary - Business Review](https://business-review.eu/wp-content/uploads/2018/10/Winners.jpg)